{
    "id": "yago_13582_0",
    "rank": 18,
    "data": {
        "url": "https://www.drugdiscoverynews.com/author/rebecca-stark",
        "read_more_link": "",
        "language": "en",
        "title": "Rebecca Stark Author Profile",
        "top_image": "https://cdn.drugdiscoverynews.com/assets/articleNo/15930/aImg/41363/68314-1800-x-900-s.jpg",
        "meta_img": "",
        "images": [
            "https://cdn.drugdiscoverynews.com/assets/authorNo/427/iImg/40797/screenshot-2023-10-25-at-2-16-59-pm-1-t.png",
            "https://cdn.drugdiscoverynews.com/assets/articleNo/15930/aImg/41363/68314-1800-x-900-s.jpg",
            "https://cdn.drugdiscoverynews.com/assets/articleNo/15884/aImg/41194/66489-1800-x-900-s.jpg",
            "https://cdn.drugdiscoverynews.com/assets/articleNo/15876/aImg/41143/66171-1800-x-900-s.jpg",
            "https://cdn.drugdiscoverynews.com/assets/articleNo/15788/aImg/40786/62594-s.jpg",
            "https://cdn.drugdiscoverynews.com/static/12.3.0/assets/img_ddn_enewsletter_weekly_round_2023.png",
            "https://cdn.drugdiscoverynews.com/assets/magazineIssueNo/2023/iImg/41572/screenshot-2024-06-27-153336-1-s.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Rebecca Stark"
        ],
        "publish_date": null,
        "summary": "",
        "meta_description": "Author profile for Rebecca Stark",
        "meta_lang": "en",
        "meta_favicon": "https://cdn.drugdiscoverynews.com/static/12.3.0/drugdiscoverynews.ico",
        "meta_site_name": "",
        "canonical_link": "https://www.drugdiscoverynews.com/author/rebecca-stark",
        "text": "Leaky calcium channels may underlie ‘chemobrain’\n\nChemotherapy patients have reported cognitive impairments known as “chemobrain.” Now, researchers are closer to finding its cause and a potential treatment.\n\nPlacebo may work as well as ketamine in treating depression\n\nBy masking ketamine from placebo for the first time, researchers reveal the importance of accounting for expectancy in trials testing psychoactive drugs.\n\nA novel antibody reverses synthetic opioid-related overdose\n\nResearchers precisely engineered an antibody to better treat respiratory depression due to overdose from increasingly prevalent synthetic opioids."
    }
}